When should a phenytoin level be drawn?

When to Draw Phenytoin Levels

Phenytoin levels do not need to be routinely checked before emergency department discharge after loading, but should be monitored on an outpatient basis for dose optimization and safety. 1

Timing Based on Route of Administration

After IV Loading Dose

• Therapeutic levels (≥10 mg/L) are achieved within minutes after completion of IV phenytoin or fosphenytoin infusion 1
• No need to recheck levels before ED discharge following appropriate loading doses 1
• If levels are drawn for clinical decision-making, obtain 2 hours post-load to predict maintenance timing needs 2
  • A 2-hour level ≥22.7 mcg/mL predicts therapeutic levels will persist for 12+ hours 2
  • A 2-hour level <15.6 mcg/mL suggests earlier maintenance dosing may be needed 2

After IM Fosphenytoin

• Therapeutic levels are generally achieved within 1 hour of intramuscular administration 1
• Similar to IV dosing, routine pre-discharge levels are not necessary 1

After Oral Loading Dose

• Therapeutic levels are achieved 3-8 hours after oral loading (single or divided doses) 1
• Peak levels occur at approximately 10-11 hours after initiation of oral loading 3
• If monitoring is needed, draw levels 6-10 hours post-dose to confirm therapeutic range 1

After Maintenance Dosing Without Loading

• Steady-state levels require 3-7 days (typically 7-8 days) to achieve therapeutic range with daily maintenance dosing alone 1
• Initial level should be drawn at 7-10 days after starting maintenance therapy 4
• Some patients may never achieve therapeutic levels without dose adjustment 1

Clinical Indications for Level Monitoring

Mandatory Monitoring Situations

• Suspected toxicity: Draw immediately if patient exhibits ataxia, nystagmus, tremor, somnolence, or confusional states 1, 4
• Breakthrough seizures in patients on chronic therapy 4
• Drug interactions: When adding medications that alter phenytoin metabolism (see extensive list including acute alcohol, amiodarone, carbamazepine, valproate, etc.) 4
• Renal insufficiency (creatinine clearance <50 mL/min): More frequent monitoring required due to altered protein binding 5
• Hypoalbuminemia: Use corrected levels (Winter-Tozer equation) as total levels will be misleadingly low 6, 7

Routine Outpatient Monitoring

• Follow-up levels are important after ED discharge for dose optimization 1
• Target therapeutic range: 10-20 mcg/mL (some sources suggest 15-20 mcg/mL for high-therapeutic range) 1, 7
• Dosage adjustments should not occur more frequently than every 7-10 days due to time required to reach steady state 4

Special Populations

Overweight Patients (>120% IBW)

• Use adjusted body weight for loading dose calculations to optimize therapeutic level achievement 6
• Draw level within 6 hours post-load to assess adequacy 6
• Actual body weight dosing leads to higher rates of supratherapeutic levels (43% vs 22%) 6

Patients Receiving Enteral Nutrition

• Phenytoin absorption is significantly reduced with concurrent enteral feeding 4, 7
• Hold enteral nutrition for phenytoin administration (specific protocols vary) 7
• More frequent level monitoring may be necessary in patients receiving enteral nutrition 4

Pediatric Patients

• Draw 2-hour post-load level to guide maintenance timing 2
• Therapeutic levels maintained at 12 hours in only 50% of children after standard loading 2
• Earlier maintenance dosing may be needed based on 2-hour level 2

Common Pitfalls to Avoid

• Do not delay treatment waiting for levels after appropriate loading doses 1
• Do not use uncorrected levels in patients with albumin <4 g/dL 6, 7
• Do not make dose adjustments more frequently than every 7-10 days 4
• Do not assume therapeutic levels persist beyond 12-24 hours after loading without maintenance dosing 2
• Do not ignore drug interactions that can dramatically alter phenytoin levels (both increases and decreases possible) 4
• Consider pharmacogenetic testing (CYP2C9 and HLA-B*15:02) for dose optimization and toxicity risk assessment 8